Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Eiger BioPharmaceuticals, Inc. (EIGR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 2.1% stake in EIGER BIOPHARMACEUTICALS INC |
| 04/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| 683 Capital Management, LLC reports a 7.1% stake in Eiger BioPharmaceuticals, Inc. |
| 02/09/2023 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 0% stake in Eiger BioPharmaceuticals, Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2023 |
SC 13G/A
| Arkin Moshe reports a 6.2% stake in Eiger BioPharmaceuticals, Inc. |
| 01/10/2023 |
SC 13G/A
| AMERIPRISE FINANCIAL INC reports a 12.4% stake in Eiger BioPharmaceuticals, Inc. |
| 05/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/04/2021 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Eiger BioPharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| EcoR1 Capital, LLC reports a 1.8% stake in Eiger BioPharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Prosight Management, LP reports a 0% stake in EIGER BIOPHARMACEUTICALS, INC. |
| 02/13/2019 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 0.5% stake in Eiger BioPharmaceuticals, Inc. |
| 02/07/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 5.5% stake in EIGER BIOPHARMACEUTICALS, INC. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 6.1% stake in Eiger BioPharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Lombard Odier Asset Management Corp reports a 2% stake in Eiger BioPharmaceuticals, Inc. |
| 04/04/2016 |
SC 13G/A
| Celladon Corp reports a 1.8% stake in Eiger BioPharmaceuticals, Inc. |
|
|